ORG Partners LLC Sells 3,376 Shares of The Clorox Company (NYSE:CLX)

ORG Partners LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 80.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 821 shares of the company’s stock after selling 3,376 shares during the quarter. ORG Partners LLC’s holdings in Clorox were worth $117,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CLX. American Century Companies Inc. raised its holdings in Clorox by 18.0% during the first quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after buying an additional 1,269 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Clorox by 6.8% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after buying an additional 1,044 shares in the last quarter. Cibc World Market Inc. raised its holdings in Clorox by 276.6% during the first quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after buying an additional 6,844 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Clorox by 0.8% during the first quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock valued at $95,073,000 after buying an additional 5,145 shares in the last quarter. Finally, Blair William & Co. IL grew its position in shares of Clorox by 81.1% in the first quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after purchasing an additional 10,981 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $141.98 on Monday. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21. The firm has a 50 day moving average of $151.19 and a 200-day moving average of $141.52. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The stock has a market capitalization of $17.62 billion, a P/E ratio of 225.37, a price-to-earnings-growth ratio of 2.21 and a beta of 0.43.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the previous year, the company posted $0.98 earnings per share. Clorox’s quarterly revenue was up 16.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 761.90%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLX. UBS Group raised their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd. JPMorgan Chase & Co. raised their price target on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Monday, February 5th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Finally, The Goldman Sachs Group initiated coverage on Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 target price on the stock. Four investment analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $149.13.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.